Top 5 Medical Device Angel Investors in Switzerland (May 2026)

Portfolio highlights

• Aktiia — Founded in Switzerland in May 2018 out of a passion to turn insights into action in the fight against hypertension, Aktiia’s groundbreaking medical technology provides people and their physicians comprehensive insights into blood pressure patterns that will inform the diagnosis and management of hypertension. Now available in the United Kingdom,Aktiia has received its CE Mark as a Class IIa medical device - signifying that the device has been assessed to meet high safety, health and environmental protection requirements in Europe. To learn more, visit Aktiia.com.
• Kollabo — Kollabo - the deep job platform for skilled blue collar workers. Thanks to our large network of temporary offices & our qualified team, we excel at finding the perfect match for job seekers and staffing agencies. Never before has the recruiting process been so easy and hassle-free for everyone involved. The goal is to digitally enable allstakeholder, generating a win-win-win situation. It can be that simple with Kollabo – We make work easy.
• ExpressSteuer — ExpressSteuer is building AI-powered software that simplifies and automates the process of filing a german tax return which is considered to be the most complex and complicated in the world.

Portfolio highlights

• Lumendo — Curing with light

Portfolio highlights

• AnFin — AnFin is a venture-backed fintech company building the most innovative products in the wealth management and brokerage space. We strongly believe in the power of the stock market to transform developing economies. Therefore, we want to democratize access to stocks, bonds, and structured investment products. By leveraging scalable technology andstrategic partnerships, AnFin plans to build an ecosystem of products that connect stakeholders in a seamless way.
• Cocunat — Cocunat is a natural and 100% toxic free cosmetics brand.
• Animoca Brands — Animoca Brands is a metaverse and gaming venture capital firm that focuses on driving digital property rights to gamers and internet users through NFTs. It utilizes gamification and blockchain to develop and market a portfolio of mobile applications, games, and additional products oriented to educational learning to ensure transparency, security,and new business models.

Portfolio highlights

• TYXIT — TYXIT is linking musicians wirelessly without configuration, allowing a personal audio monitoring.
• PXL Vision — PXL Vision enables state-of-the-art digital identity verification. PXL Vision's highly flexible technology solution helps global customers build trust digitally...
• 1Drop Diagnostics — 1Drop Diagnostics is a cutting edge medical diagnostics and life science company. They combine the best techniques from microfluidics, biochemistry, photonics and information technology to build high performance point-of-care diagnostics devices.Their vision is to provide high quality medical information for everyone. They aim to increase accessto quality healthcare by providing laboratory quality, easy to use, medical diagnostics in any setting. The 1Drop Diagnostics system is being developed for a broad menu of clinical applications including multiplexed assays of proteins, nucleic acids and peptides. Their first clinical applications are in the screening, diagnostics and monitoring of cardiovascular disease and infectious disease.Their mission is to improve patient lives by enabling precision medicine through non-invasive diagnostic tests providing actionable health information that is accessible to everyone at any time. They facilitate the early detection, prevention and management of disease. They empower people to live better lives.

Portfolio highlights

• Pi-Cardia — Pi-Cardia. Next Generation Valve Repair. The next frontier of treatment options for structural heart disease that provides a safe, effective, and affordable non-implant-based catheter solutions.
• CorFlow Therapeutics AG — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.